AA

Arpitaben Amitkumar Patel

Active Director Director DIN 09400607
DIN 09400607 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Arpitaben Amitkumar Patel

Data last updated:

Arpitaben Amitkumar Patel is a Director at Craton Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Craton Pharmaceuticals Private Limited reported revenue of ₹12.4 Lakh (FY 2021).

DIN 09400607
Primary Designation Director
Industry Pharma
First Appointment 20 Nov 2021
Oldest Company Age 7 yrs
Largest company Craton Pharmaceuticals Private Limited · ₹12.4 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20212018₹12.4 Lakh (FY 2021)Active

Board colleagues of Arpitaben Amitkumar Patel

Directorship timeline

Open interactive timeline →
Craton Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Arpitaben Amitkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpitaben Amitkumar Patel

Arpitaben Amitkumar Patel currently holds 1 directorship: Craton Pharmaceuticals Private Limited (Director, since 20 Nov 2021, revenue ₹12.4 Lakh (FY 2021)).

Arpitaben Amitkumar Patel was first appointed on 20 Nov 2021 as Director at Craton Pharmaceuticals Private Limited.

The current boards of Arpitaben Amitkumar Patel's companies include Gaurav Girishchandra Pandya (Craton Pharmaceuticals Private Limited), Nishith Dilipbhai Pathak (Craton Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available